CLN6 Peptide - C-terminal region (AAP47372)

Data Sheet
Sku AAP47372
Old sku AAPP28240
Price $99.00
Name CLN6 Peptide - C-terminal region (AAP47372)
Purchase info To purchase this peptide:
  • Copy peptide sku
  • Click on this link
  • Paste into field "Peptide Sku"
Size 100 ug
Gene CLN6
Alias symbols FLJ20561, HsT18960, nclf, CLN4A
Gene id 54982
Description of target CLN6 is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely CLN6 involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.
Swissprot id Q9NWW5
Protein accession num NP_060352
Nucleotide accession num NM_017882
Protein size 311 amino acids
Molecular weight 36kDa
Application IHC, WB
Quality control The peptide is characterized by mass spectroscopy
Key reference Heine,C., (2007) Mol. Membr. Biol. 24 (1), 74-87
Description This is a synthetic peptide designed for use in combination with anti-CLN6 antibody (Catalog #: ARP47372_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Product format Lyophilized powder
Reconstitution and storage Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.
Lead time Domestic: within 24 hours delivery  International: 3-5 business days

See our General FAQ page.

Availability In Stock

AVIVA SYSTEMS BIOLOGY manufactures and sells quality antibody products covering genome wide proteins.

6370 Nancy Ridge Dr., Suite 104, San Diego, CA 92121 USA | Tel: (858)552-6979 |